# Grace Therapeutics, Inc.: insider transactions

GRCE · Nasdaq · CIK 1444192 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/grce.md) · [Financials](/companies/grce/financials.md) · [Filings](/companies/grce/filings.md) · [Insiders](/companies/grce/insiders.md)

## All transactions: 2

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-26 | [Opaleye Management Inc.](/insiders/1595855.md) | 10% owner | Purchase (P) | 66,411 | $1.7679 | $117.4k | [Form 4](/filings/0001493152-26-048591.md) |
| 2026-10-22 | [Opaleye Management Inc.](/insiders/1595855.md) | 10% owner | Purchase (P) | 21,390 | $1.9258 | $41.2k | [Form 4](/filings/0001493152-26-048591.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 26, 2026, 18:07 ET. No prices; not investment advice.